Wilms' tumor risk factors

Jump to navigation Jump to search

Wilms' tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Wilms' Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wilms' tumor risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilms' tumor risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilms' tumor risk factors

CDC on Wilms' tumor risk factors

Wilms' tumor risk factors in the news

Blogs on Wilms' tumor risk factors

Directions to Hospitals Treating Wilms' tumor

Risk calculators and risk factors for Wilms' tumor risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sargun Singh Walia M.B.B.S.[2],Shanshan Cen, M.D. [3]

Overview

Common risk factors in the development of wilms tumor include familial wilms tumor, congenital anomalies, WT-1 related syndromes and WT2-related syndromes. Less common risk factors in the development of wilms tumor include perlman syndrome, simpson-golabi-ehemel syndrome, Sotos syndrome, 9q22.3 microdeletion syndrome, Bloom syndrome, li-fraumeni syndrome and Alagille syndrome.

Risk factors

Common Risk Factors

Less Common Risk Factors

References

  1. National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq
  2. National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/publications/pdq
  3. Crider-Miller SJ, Reid LH, Higgins MJ, Nowak NJ, Shows TB, Futreal PA, Weissman BE (December 1997). "Novel transcribed sequences within the BWS/WT2 region in 11p15.5: tissue-specific expression correlates with cancer type". Genomics. 46 (3): 355–63. doi:10.1006/geno.1997.5061. PMID 9441738.
  4. Morris MR, Astuti D, Maher ER (May 2013). "Perlman syndrome: overgrowth, Wilms tumor predisposition and DIS3L2". Am J Med Genet C Semin Med Genet. 163C (2): 106–13. doi:10.1002/ajmg.c.31358. PMID 23613427.
  5. Alton KB, Patrick JE, Shaw C, McGuire JL (1975). "Comparative biotransformation of triflubazam in rats, dogs, and monkeys". Drug Metab. Dispos. 3 (6): 445–52. PMID 1219.
  6. Heller BR, Walsh FJ (January 1976). "Changing nursing students' attitudes toward the aged: an experimental study". J Nurs Educ. 15 (1): 9–17. PMID 1479.
  7. Berger C, Frappaz D, Leroux D, Blez F, Vercherat M, Bouffet E, Jalbert P, Brunat-Mentigny M (August 1996). "[Wilms tumor and Bloom syndrome]". Arch Pediatr (in French). 3 (8): 802–5. PMID 8998536.
  8. Hartley AL, Birch JM, Tricker K, Wallace SA, Kelsey AM, Harris M, Jones PH (June 1993). "Wilms' tumor in the Li-Fraumeni cancer family syndrome". Cancer Genet. Cytogenet. 67 (2): 133–5. PMID 8392435.
  9. Bourdeaut F, Guiochon-Mantel A, Fabre M, Martelli H, Patte C, Porta G, Bernard O, Delattre O, Jacquemin E (April 2008). "Alagille syndrome and nephroblastoma: Unusual coincidence of two rare disorders". Pediatr Blood Cancer. 50 (4): 908–11. doi:10.1002/pbc.21255. PMID 17584876.